Black Friday saleUp to 70% OFF
SHANGHAI MICROPORT MEDBOT (GROUP) CSHANGHAI MICROPORT MEDBOT (GROUP) CSHANGHAI MICROPORT MEDBOT (GROUP) C

SHANGHAI MICROPORT MEDBOT (GROUP) C

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

2252 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. Its product portfolio covers surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures. Its products include Toumai, DFVision, and SkyWalker. The company was founded on May 11, 2015 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2252 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company